Concepedia

David Semel

DS

4

Publications

176

Citations

4

H-Index

2010

Active since

Affiliations

Pfizer (United States)(Current)

David Semel is an author at Pfizer (United States) specializing in pain management, rehabilitation, and clinical trials.

Top concepts

HivHealthMedicineNeurologyPharmacologyPain MedicinePain ResearchRehabilitationClinical TrialsPain Management

Publications per year

2010–2016

4

Publications

4

Evaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studies

David Semel, T.K. Murphy, Gergana Zlateva et al. · BMC Family Practice · 2010 · 86 citations · Full text

A randomized, double-blind, placebo-controlled trial and open-label extension study to evaluate the efficacy and safety of pregabalin in the treatment of neuropathic pain associated with human immunodeficiency virus neuropathy

David M. Simpson, Andrew S.C. Rice, Birol Emir et al. · Pain · 2014 · 53 citations

Pain Therapy, Open-label Extension Study, Pain Medicine +18

Effects of Pregabalin in Patients with Neuropathic Pain Previously Treated with Gabapentin: A Pooled Analysis of Parallel‐Group, Randomized, Placebo‐controlled Clinical Trials

John D. Markman, Troels S. Jensen, David Semel et al. · Pain Practice · 2016 · 26 citations

Costs and Work Loss Burden of Diagnosed Opioid Abuse Among Employees on Workers Compensation or Short-term Disability

Stephen S. Johnston, A. Alexander, Elizabeth T. Masters et al. · Journal of Occupational and Environmental Medicine · 2016 · 11 citations

Rows per page

1–4 of 4